These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36269317)

  • 41. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Satisfaction with Detrusor OnabotulinumtoxinA Injections and Conversion to Other Bladder Management in Patients with Chronic Spinal Cord Injury.
    Chen SF; Jiang YH; Jhang JF; Kuo HC
    Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of detrusor botulinum toxin a injection on urothelial dysfunction in patients with chronic spinal cord injury: a clinical and immunohistochemistry study before and after treatment.
    Chen SF; Chang CH; Kuo HC
    Spinal Cord; 2016 Oct; 54(10):889-894. PubMed ID: 26832760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and Safety of AbobotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results from Two Phase 3 Randomized Studies (CONTENT1 and CONTENT2).
    Kennelly M; Cruz F; Herschorn S; Abrams P; Onem K; Solomonov VK; Del Rosario Figueroa Coz E; Manu-Marin A; Giannantoni A; Thompson C; Vilain C; Volteau M; Denys P;
    Eur Urol; 2022 Aug; 82(2):223-232. PubMed ID: 35400537
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Botulinum toxin A injection for the treatment of neurogenic detrusor overactivity secondary to spinal cord injury: multi-institutional experience in Japan.
    Sengoku A; Okamura K; Kimoto Y; Ogawa T; Namima T; Yamanishi T; Yokoyama T; Akino H; Maeda Y
    Int J Urol; 2015 Mar; 22(3):306-9. PubMed ID: 25403926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder.
    Chen SF; Chang CH; Kuo HC
    Toxins (Basel); 2016 May; 8(6):. PubMed ID: 27249005
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Giannantoni A; Mearini E; Del Zingaro M; Porena M
    Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discontinuation rates and inter-injection interval for repeated intravesical botulinum toxin type A injections for detrusor overactivity.
    Veeratterapillay R; Harding C; Teo L; Vasdev N; Abroaf A; Dorkin TJ; Pickard RS; Hasan T; Thorpe AC
    Int J Urol; 2014 Feb; 21(2):175-8. PubMed ID: 23819724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed.
    Bottet F; Peyronnet B; Boissier R; Reiss B; Previnaire JG; Manunta A; Kerdraon J; Ruffion A; Lenormand L; Perrouin Verbe B; Gaillet S; Gamé X; Karsenty G;
    Neurourol Urodyn; 2018 Jan; 37(1):291-297. PubMed ID: 28431196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Botulinum toxin A for treatment of neurogenic detrusor overactivity and incontinence in patients with spinal cord lesions.
    Bagi P; Biering-Sørensen F
    Scand J Urol Nephrol; 2004; 38(6):495-8. PubMed ID: 15841785
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of repeated detrusor onabotulinumtoxinA injections on bladder and renal function in patients with chronic spinal cord injuries.
    Kuo HC; Liu SH
    Neurourol Urodyn; 2011 Nov; 30(8):1541-5. PubMed ID: 21717505
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic outcome and quality of life between urethral and detrusor botulinum toxin treatment for patients with spinal cord lesions and detrusor sphincter dyssynergia.
    Kuo HC
    Int J Clin Pract; 2013 Oct; 67(10):1044-9. PubMed ID: 24073977
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Botulinum toxin type A injection for neurogenic detrusor overactivity: clinical outcome in Japanese patients.
    Hikita K; Honda M; Kawamoto B; Panagiota T; Inoue S; Hinata N; Muraoka K; Takenaka A
    Int J Urol; 2013 Jan; 20(1):94-9. PubMed ID: 23126535
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Botulinum toxin for treatment of urinary incontinence due to detrusor overactivity: a systematic review of effectiveness and adverse effects.
    MacDonald R; Fink HA; Huckabay C; Monga M; Wilt TJ
    Spinal Cord; 2007 Aug; 45(8):535-41. PubMed ID: 17453012
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of augmentation cystoplasty and botulinum toxin injection on patient-reported bladder function and quality of life among individuals with spinal cord injury performing clean intermittent catheterization.
    Myers JB; Lenherr SM; Stoffel JT; Elliott SP; Presson AP; Zhang C; Rosenbluth J; Jha A; Patel D; Welk B;
    Neurourol Urodyn; 2019 Jan; 38(1):285-294. PubMed ID: 30375055
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is repeat Botulinum Toxin A injection valuable for neurogenic detrusor overactivity-A systematic review and meta-analysis.
    Ni J; Wang X; Cao N; Si J; Gu B
    Neurourol Urodyn; 2018 Feb; 37(2):542-553. PubMed ID: 28745818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Botulinum Toxin Injection for Medically Refractory Neurogenic Bladder in Children: A Systematic Review.
    Wu SY; Chang SJ; Yang SS; Hsu CK
    Toxins (Basel); 2021 Jun; 13(7):. PubMed ID: 34203333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravesical botulinum-A toxin in children with refractory non-neurogenic overactive bladder.
    Lambregts AP; Nieuwhof-Leppink AJ; Klijn AJ; Schroeder RPJ
    J Pediatr Urol; 2022 Jun; 18(3):351.e1-351.e8. PubMed ID: 35283021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Onabotulinum toxin A for the treatment of neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis.
    Goessaert AS; Everaert KC
    Expert Rev Neurother; 2012 Jul; 12(7):763-75. PubMed ID: 22853784
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Switching from onabotulinum toxin A to abobotulinum toxin A for treating detrusor overactivity in spinal cord injured patient, does it really work?
    Le Roy C; Lefèvre C; Lepoittevin L; Reiss B; Le Fort M; Rigaud J; Perrouin-Verbe B; Perrouin-Verbe MA
    Prog Urol; 2023 Sep; 33(10):503-508. PubMed ID: 37550178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.